Ortin Global Limited (BOM:539287)

India flag India · Delayed Price · Currency is INR
16.89
-0.81 (-4.58%)
At close: Mar 9, 2026
35.88%
Market Cap 137.34M
Revenue (ttm) 1.12M
Net Income (ttm) -8.95M
Shares Out 8.13M
EPS (ttm) -1.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 42
Average Volume 13,037
Open 18.00
Previous Close 17.70
Day's Range 16.89 - 18.00
52-Week Range 9.57 - 19.15
Beta 0.44
RSI 55.76
Earnings Date Feb 14, 2026

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulceran... [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Employees 3
Stock Exchange Bombay Stock Exchange
Ticker Symbol 539287
Full Company Profile

Financial Performance

In fiscal year 2025, Ortin Global's revenue was 3.43 million, a decrease of -84.61% compared to the previous year's 22.26 million. Losses were -8.46 million, -89.47% less than in 2024.

Financial Statements

News

There is no news available yet.